Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Peri-hilar cholangiocarcinoma (phCCA): A comparative comprehensive genomic profiling study.
Authors
Parth J Sampat
SUNY Upstate Medical University, Syracuse, NY
Parth J Sampat , Dean C. Pavlick , Jeffrey S. Ross , Alina Basnet
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 542)
DOI
10.1200/JCO.2024.42.3_suppl.542
Abstract #
542
Poster Bd #
F9
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Profiling of 3,634 cholangiocarcinomas (CCA) to identify genomic alterations (GA), tumor mutational burden (TMB), and genomic loss of heterozygosity (gLOH).
First Author: Milind M. Javle
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Landscape of BRAF mutation classes in intrahepatic cholangiocarcinoma.
First Author: Tin-Yun Tang
Poster
2019 ASCO Annual Meeting
Comprehensive genomic profiling in FIGHT-202 reveals the landscape of actionable alterations in advanced cholangiocarcinoma.
First Author: Ian M. Silverman
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Circulating tumor DNA-based genomic landscape of early-onset pancreatic cancer.
First Author: Reagan Barnett